Join us at any stage of your wellness journey. Upcoming dates in Coeur d'Alene.
In the emerging realm of psychedelics, ketamine is the only legally available psychedelic medicine. Ketamine has been an FDA-approved anesthetic since 1970 and is used safely at lower doses as an off-label for depression treatment, as well as anxiety, PTSD, OCD, and other diagnoses. Ketamine increases neuroplasticity (the ability to create new neural connections) and suppresses the default mode network (DMN), which is often the culprit of negative and ruminating thought patterns. We welcome you to visit the recommended reading section on this page to learn more about Ketamine.
While every non-ordinary states experience is unique, many people describe shifts in consciousness such as expanded states of awareness, dream-like states or out of body experiences. In a group setting people may experience an enhanced feeling of joining a collective or sense of oneness.
You can contact us through the “Contact” tab and we will walk you through determining if our retreats may benefit you and help you through the registration process. All retreats require medical screening and clearance prior to attendance.
Bennett, R. (2019). Paradigms of ketamine treatment. MAPS Bulletin, 29(1).
Oaklander, M. (2017). New hope for depression. TIME. https://time.com/magazine/us/4876068/august-7th-2017-vol-190-no-6-u-s/
Mathai, D. S., Meyer, M. J., Storch, E. A., & Kosten, T. R. (2020). The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders, 264, 123-129. https://doi.org/10.1016/j.jad.2019.12.023
Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy, Journal of Psychoactive Drugs, 51(2), 189-198. DOI: 10.1080/02791072.2019.1587556 https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1587556
Mathai, D., Mora, V. & Garcia-Romeu, A. (2022). Toward Synergies of Ketamine and Psychotherapy. Frontiers in Psychiatry, Vol 13. https://www.frontiersin.org/articles/10.3389/fpsyg.2022.868103
Liriano, F., Hatten, C., & Schwartz, T. L. (2019). Ketamine as treatment for post-traumatic stress disorder: A review. Drugs in context, 8, 212305. DOI: 10.7573/dic.212305 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457782/
Pacific Northwest Ketamine Retreats
Copyright © 2022 Kerry Green - All Rights Reserved.